A Study to Evaluate Pharmacokinetics (PK) and Safety of Inaxaplin in Participants With Renal Impairment
Clinical trial NCT05865171 · COMPLETED
Trial details
- NCT number
- NCT05865171
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-12
- Primary completion
- 2024-06-12
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.